• Amylyx Pharmaceuticals raises $135M as ALS drug heads to pivotal clinical trial

    3 monthes ago - By MedCity News

    An amyotrophic lateral sclerosis drug from Amylyx Pharmaceuticals is being prepared for Phase 3 clinical testing on track to begin later this quarter. To support that research, the biotech has raised $135 million in financing.
    Read more ...